The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Intravenous autologous bone marrow mononuclear cells for ischemic stroke
Abstract
Objective: Cellular therapy is an investigational approach for stroke. Mononuclear cells (MNCs) from the bone marrow reduce neurological deficits in animal stroke models. We determined if autologous MNC infusion was feasible and safe in patients with ischemic stroke. Methods: We conducted an open‐label prospective study of a bone marrow harvest followed by readministration of autologous MNCs in 10 patients, 18 to 80 years old, with acute middle cerebral artery ischemic stroke. Bone marrow was aspirated from the iliac crest, and MNCs were separated at a Good Manufacturing Practices facility and administered intravenously up to a maximum of 10 million cells/kg. The harvest and infusion had to occur between 24 and 72 hours after stroke. Patients were monitored for 6 months. Results: Bone marrow aspiration was successfully completed in all patients. Eight received 10 million cells/kg, and 2 received ≥7 million cells/kg. There were no significant adverse events related to harvest or infusion. Two patients had infarct expansion between enrollment and harvest and underwent hemicraniectomy after cell infusion. One patient died at 40 days due to a pulmonary embolism related to the stroke. There were no study‐related severe adverse events. Median National Institutes of Health Stroke Scale score was 13 before harvest, 8 at 7 days, and 3 at 6 months. At 6 months, all surviving patients had shifted down by at least 1 point on the modified Rankin Scale compared to day 7. Seven of 10 patients achieved a Barthel Index ≥90. Interpretation: This study suggests that a bone marrow harvest and reinfusion of autologous MNCs were safe and feasible in acute stroke patients. ANN NEUROL 2011;
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fischer, U. M., Harting, M. T., Jimenez, F., Monzon-Posadas, W. O., Xue, H., Savitz, S. I., Laine, G. A., & Cox, C. S. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0253 · Cited by 1,292
Self-citationAutologous mesenchymal stem cell transplantation in stroke patients
Bang, O. Y., Lee, J. S., Lee, P. H., & Lee, G. (2005) · Annals of Neurology · doi:10.1002/ana.20501 · Cited by 1,102
Adult Bone Marrow–Derived Cells for Cardiac Repair: A Systematic Review and Meta-analysis
Abdel-Latif, A. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.10.989 · Cited by 880
Transplantation of cultured human neuronal cells for patients with stroke
Kondziolka, D., Wechsler, L., Goldstein, S., Meltzer, C., Thulborn, K. R., Gebel, J., Jannetta, P., DeCesare, S., Elder, E. M., McGrogan, M., et al. (2000) · Neurology · doi:10.1212/wnl.55.4.565 · Cited by 629
Baird, A. E., Benfield, A., Schlaug, G., Siewert, B., Lövblad, K., Edelman, R. R., & Warach, S. (1997) · Annals of Neurology · doi:10.1002/ana.410410506 · Cited by 581
Neurotransplantation for patients with subcortical motor stroke: a Phase 2 randomized trial
Kondziolka, D., Steinberg, G. K., Wechsler, L., Meltzer, C. C., Elder, E., Gebel, J., DeCesare, S., Jovin, T., Zafonte, R., Lebowitz, J., et al. (2005) · Journal of Neurosurgery · doi:10.3171/jns.2005.103.1.0038 · Cited by 451
Iihoshi, S., Honmou, O., Houkin, K., Hashi, K., & Kocsis, J. D. (2004) · Brain Research · doi:10.1016/j.brainres.2003.09.084 · Cited by 240
Participants, T. S. (2009) · Stroke · doi:10.1161/strokeaha.108.526863 · Cited by 237
Savitz, S. I., Dinsmore, J., Wu, J., Henderson, G. V., Stieg, P., & Caplan, L. R. (2005) · Cerebrovascular Diseases · doi:10.1159/000086518 · Cited by 227
Self-citationMarrow stromal cell transplantation in stroke and traumatic brain injury
Li, Y., & Chopp, M. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2008.03.096 · Cited by 222
Cited by
Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine
Murphy, M. B., Moncivais, K., & Caplan, A. I. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.94 · Cited by 1,231
Doeppner, T. R., Herz, J., Görgens, A., Schlechter, J., Ludwig, A.-K., Radtke, S., de Miroschedji, K., Horn, P. A., Giebel, B., & Hermann, D. M. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0078 · Cited by 772
Novel Stroke Therapeutics: Unraveling Stroke Pathophysiology and Its Impact on Clinical Treatments
George, P. M., & Steinberg, G. K. (2015) · Neuron · doi:10.1016/j.neuron.2015.05.041 · Cited by 393
Hess, D. C., Wechsler, L. R., Clark, W. M., Savitz, S. I., Ford, G. A., Chiu, D., Yavagal, D. R., Uchino, K., Liebeskind, D. S., Auchus, A. P., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30046-7 · Cited by 367
Self-citationMesenchymal Stem Cells for Neurological Disorders
Andrzejewska, A., Dabrowska, S., Lukomska, B., & Janowski, M. (2021) · Advanced Science · doi:10.1002/advs.202002944 · Cited by 359
Metadata
- Authors
- Savitz, S. I., Misra, V., Kasam, M., Juneja, H., Cox, C. S., Alderman, S., Aisiku, I., Kar, S., Gee, A., & Grotta, J. C.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2011-07
- Volume
- 70
- Issue
- 1
- Pages
- 59-69
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2169898931
- Cited by
- 291
- References
- 21
- FWCI
- 10.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intravenous autologous bone marrow mononuclear cells for ischemic stroke. https://app.cochat.ai/papers/10.1002/ana.22458
- The paper
- Savitz, S. I., Misra, V., Kasam, M., Juneja, H., Cox, C. S., Alderman, S., Aisiku, I., Kar, S., Gee, A., & Grotta, J. C. (2011). Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Annals of Neurology. https://doi.org/10.1002/ana.22458
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.